Refractory IHCA and OHCA Treated With ECMO (SEAC)
|ClinicalTrials.gov Identifier: NCT01298050|
Recruitment Status : Unknown
Verified July 2011 by University of Milano Bicocca.
Recruitment status was: Recruiting
First Posted : February 17, 2011
Last Update Posted : August 4, 2011
|Condition or disease||Intervention/treatment|
|Cardiac Arrest||Procedure: ECMO|
|Study Type :||Observational|
|Estimated Enrollment :||40 participants|
|Official Title:||Refractory In and Out of Hospital Cardiac Arrest Treated With Extracorporeal Membrane Oxygenation. Observational, Single Centre, Prospective Study.|
|Study Start Date :||July 2011|
|Estimated Primary Completion Date :||July 2012|
|Estimated Study Completion Date :||July 2013|
Extracorporeal Membrane Oxygenation
All patients have to start ECMO under CPR, by insertion of peripheral VA cannulas.
Insertion of peripheral Veno-Arterious ECMO, subsequent therapeutic hypothermia
- 28 days survival [ Time Frame: 28 days ]
- Neurologic recovery [ Time Frame: 28 days ]Neurologic recovery defined as minimal neurologic impairment according to the Glasgow-Pittsburgh cerebral performance categories score ≤ 2.
- Cardiac recovery [ Time Frame: 28 days ]Measured by echocardiography
- Six months survival with minimal neurologic impairment [ Time Frame: 180 days ]survival with minimal neurologic impairment according to the Glasgow-Pittsburgh cerebral performance categories score ≤ 2.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01298050
|Principal Investigator:||Leonelllo Avalli, MD||Ospedale San Gerardo|